The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer

American Journal of Surgery

Volumn 186, Issue 4, 2003, Pages 348-350

  Lee, Susan H ^a   Chung, Maureen A ^a,b,d   Quddus, M Ruhul ^a,c   Steinhoff, Margaret M ^a,c   Cady, Blake ^a,b  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

Breast cancer; Hormone receptor status; Neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; AGE; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR BIOPSY; ADJUVANT THERAPY; BREAST TUMOR; METABOLISM;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; NEOADJUVANT THERAPY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0142151070     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(03)00271-X     Document Type: Article

References (6)

1. Singletary S.E. Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer. Am J Surg. 182:2001;341-346.
2. Mamounas E.P., Fisher B. Preoperative (neoadjuvant) chemotherapy in patients with breast cancer. Semin Oncol. 28:2001;389-399.
3. van der Hage J.A., van de Velde C.J., Julien J.P., et al. Preoperative chemotherapy in primary operable breast cancer results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol. 19:2001;4224-4237.
4. Jain V., Landry M., Levine E.A. The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma. Am Surg. 62:1996;162-165.
5. Makris A., Powles T.J., Allred D.C., et al. Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer a pilot study. Breast Cancer Res Treat. 53:1999;51-59.
6. Schneider J., Lucas R., Sanchez J., et al. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer correlation with the response to therapy and the expression of MDRI and LRP. Anticancer Res. 20:2000;4373-4377.